ARTICLE | Clinical News
LDP-341: Phase I
November 13, 2000 8:00 AM UTC
In multiple Phase I trials in a total of 100 patients with end stage cancer, various intravenous dosing regimens of LDP-341 were well tolerated, with the maximum tolerated dose not yet reached in most...